ONDANSETRON ACCORD 2 mg/ml, solution for injection 10 ampoules of 4 ml
Active ingredients: Ondansetron hydrochloride hydrate, Ondansetron
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 ampoules of 4 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ONDANSETRON ACCORD 2 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 ampoule(s) en verre brun de 4 ml
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Jan 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69422609CIP75500324CIP133400955003243Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'ONDANSÉTRON DIHYDRATÉsolution | 2,5 mg · 1 ml | SA |
| ONDANSÉTRONsolution | 2 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.